Suivre
Kristof Theys
Titre
Citée par
Citée par
Année
Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study
J Gregson, M Tang, N Ndembi, RL Hamers, SY Rhee, VC Marconi, ...
The Lancet infectious diseases 16 (5), 565-575, 2016
2772016
HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics
AB Abecasis, AMJ Wensing, D Paraskevis, J Vercauteren, K Theys, ...
Retrovirology 10, 1-13, 2013
1812013
An integrated map of HIV genome-wide variation from a population perspective
G Li, S Piampongsant, NR Faria, A Voet, AC Pineda-Peña, R Khouri, ...
Retrovirology 12, 1-18, 2015
1512015
Computational strategies to combat COVID-19: useful tools to accelerate SARS-CoV-2 and coronavirus research
F Hufsky, K Lamkiewicz, A Almeida, A Aouacheria, C Arighi, A Bateman, ...
Briefings in bioinformatics 22 (2), 642-663, 2021
1422021
CRF19_cpx is an evolutionary fit HIV-1 variant strongly associated with rapid progression to AIDS in Cuba
V Kouri, R Khouri, Y Alemán, Y Abrahantes, J Vercauteren, ...
EBioMedicine 2 (3), 244-254, 2015
842015
Genetic diversity and selective pressure in hepatitis C virus genotypes 1–6: significance for direct-acting antiviral treatment and drug resistance
L Cuypers, G Li, P Libin, S Piampongsant, AM Vandamme, K Theys
Viruses 7 (9), 5018-5039, 2015
802015
Functional conservation of HIV-1 Gag: implications for rational drug design
G Li, J Verheyen, SY Rhee, A Voet, AM Vandamme, K Theys
Retrovirology 10, 1-11, 2013
752013
A computational method for the identification of Dengue, Zika and Chikungunya virus species and genotypes
V Fonseca, PJK Libin, K Theys, NR Faria, MRT Nunes, MI Restovic, ...
PLoS neglected tropical diseases 13 (5), e0007231, 2019
662019
The incidence of multidrug and full class resistance in HIV-1 infected patients is decreasing over time (2001–2006) in Portugal
J Vercauteren, K Deforche, K Theys, M Debruyne, LM Duque, S Peres, ...
Retrovirology 5, 1-8, 2008
652008
VIRULIGN: fast codon-correct alignment and annotation of viral genomes
PJK Libin, K Deforche, AB Abecasis, K Theys
Bioinformatics 35 (10), 1763-1765, 2019
572019
HIV-1 genotypic drug resistance testing: digging deep, reaching wide?
K Van Laethem, K Theys, AM Vandamme
Current opinion in virology 14, 16-23, 2015
542015
The impact of HIV-1 within-host evolution on transmission dynamics
K Theys, P Libin, AC Pineda-Pena, A Nowe, AM Vandamme, AB Abecasis
Current opinion in virology 28, 92-101, 2018
512018
HIV-1 subtype is an independent predictor of reverse transcriptase mutation K65R in HIV-1 patients treated with combination antiretroviral therapy including tenofovir
K Theys, J Vercauteren, J Snoeck, M Zazzi, RJ Camacho, C Torti, ...
Antimicrobial agents and chemotherapy 57 (2), 1053-1056, 2013
482013
Covering all bases in HIV research: unveiling a hidden world of viral evolution.
B Vrancken, S Lequime, K Theys, P Lemey
AIDS reviews 12 (2), 89-102, 2010
372010
Within-patient mutation frequencies reveal fitness costs of CpG dinucleotides and drastic amino acid changes in HIV
K Theys, AF Feder, M Gelbart, M Hartl, A Stern, PS Pennings
PLoS genetics 14 (6), e1007420, 2018
36*2018
Treatment-associated polymorphisms in protease are significantly associated with higher viral load and lower CD4 count in newly diagnosed drug-naive HIV-1 infected patients
K Theys, K Deforche, J Vercauteren, P Libin, DAMC van de Vijver, J Albert, ...
Retrovirology 9, 1-13, 2012
332012
RegaDB: community-driven data management and analysis for infectious diseases
P Libin, G Beheydt, K Deforche, S Imbrechts, F Ferreira, K Van Laethem, ...
Bioinformatics 29 (11), 1477-1480, 2013
322013
Modelled in vivo HIV Fitness under drug Selective Pressure and Estimated Genetic Barrier Towards Resistance are Predictive for Virological Response
EuroSIDA Study Group
Antiviral Therapy 13 (3), 399-408, 2008
322008
SANTA-SIM: simulating viral sequence evolution dynamics under selection and recombination
A Jariani, C Warth, K Deforche, P Libin, AJ Drummond, A Rambaut, ...
Virus evolution 5 (1), vez003, 2019
292019
Sub-epidemics explain localized high prevalence of reduced susceptibility to rilpivirine in treatment-naive HIV-1-infected patients: subtype and geographic compartmentalization …
K Theys, K Van Laethem, P Gomes, G Baele, AC Pineda-Pena, ...
AIDS research and human retroviruses 32 (5), 427-433, 2016
242016
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20